Evidence map›Paper›PMID 33532747›Full record

ArticleFrontiers in medical technology2020

Robust Formation of an Epithelial Layer of Human Intestinal Organoids in a Polydimethylsiloxane-Based Gut-on-a-Chip Microdevice.

Woojung Shin, Yoko M Ambrosini, Yong Cheol Shin, Alexander Wu, Soyoun Min, Domin Koh, Sowon Park, Seung Kim, Hong Koh, Hyun Jung Kim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medical technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Engineering the Extracellular Matrix for Organoid Culture.International journal of stem cells · 2022
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Woojung ShinDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Yoko M AmbrosiniDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Yong Cheol ShinDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Alexander WuDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Soyoun MinDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Domin KohDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
Sowon ParkSeverance Fecal Microbiota Transplantation Center, Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea.
Seung KimSeverance Fecal Microbiota Transplantation Center, Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea.
Hong KohSeverance Fecal Microbiota Transplantation Center, Severance Hospital, Department of Pediatrics, Yonsei University College of Medicine, Seoul, South Korea.
Hyun Jung KimDepartment of Biomedical Engineering, The University of Texas at Austin, Austin, TX, United States.
The University of Texas at Austin · USYonsei University · KR

Funding

A personalized colorectal cancer-on-a-chip for assessing tumor-microbiome crosstalkR21CA236690 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI KIM, HYUN JUNG · 2019 to 2021
$523k
Investigation of the Carcinogenic Effects of Bactericidal Antibiotics in the GutK00CA245801 · NCI · HARVARD UNIVERSITY · PI SHIN, WOOJUNG · 2021 to 2023
$278k
Deciphering the Role of Gut Microbiome in Colitis-Associated Colorectal Cancer Using a Patient-Specific Disease-on-a-ChipF99CA245801 · NCI · UNIVERSITY OF TEXAS AT AUSTIN · PI SHIN, WOOJUNG · 2019 to 2020
$75k
NCI NIH HHS F99 CA245801NCI NIH HHS K00 CA245801NCI NIH HHS R21 CA236690
6 · The paper itself

Abstract

Polydimethylsiloxane (PDMS) is a silicone polymer that has been predominantly used in a human organ-on-a-chip microphysiological system. The hydrophobic surface of a microfluidic channel made of PDMS often results in poor adhesion of the extracellular matrix (ECM) as well as cell attachment. The surface modification by plasma or UV/ozone treatment in a PDMS-based device produces a hydrophilic surface that allows robust ECM coating and the reproducible attachment of human intestinal immortalized cell lines. However, these surface-activating methods have not been successful in forming a monolayer of the biopsy-derived primary organoid epithelium. Several existing protocols to grow human intestinal organoid cells in a PDMS microchannel are not always reproducibly operative due to the limited information. Here, we report an optimized methodology that enables robust and reproducible attachment of the intestinal organoid epithelium in a PDMS-based gut-on-a-chip. Among several reported protocols, we optimized a method by performing polyethyleneimine-based surface functionalization followed by the glutaraldehyde cross linking to activate the PDMS surface. Moreover, we discovered that the post-functionalization step contributes to provide uniform ECM deposition that allows to produce a robust attachment of the dissociated intestinal organoid epithelium in a PDMS-based microdevice. We envision that our optimized protocol may disseminate an enabling methodology to advance the integration of human organotypic cultures in a human organ-on-a-chip for patient-specific disease modeling.

Indexed as

cell attachmentextracellular matrixgut-on-a-chiphydrophobicityorganoidspolydimethylsiloxanesurface functionalization

Identifiers

PMID33532747
PMCPMC7849371
OpenAlexW3047699873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.